Table 1 Demographic characteristics, comorbidities, and laboratory results with comprehensive geriatric assessments, categorized by Sarcopenia status (Bold values indicate statistically significant results p < 0.05)
Total n = 632 | Non sarcopenic n = 536 | Sarcopenic n = 96 | p | |
|---|---|---|---|---|
Age, mean (SD) | 74.8 (6.4) | 74.2 (6.1) | 78.2 (6.6) | < 0.001 |
Sex, n (%) Female Male | 394 (62.3) 238 (37.7) | 334 (62.3) 202 (37.7) | 60 (62.5) 36 (37.5) | 0.97 |
Diabetes Mellitus, n (%) | 197 (31.2) | 166 (31) | 31 (32.3) | 0.79 |
Hypertension, n (%) | 433 (68.5) | 367 (68.5) | 66 (68.8) | 0.95 |
Atherosclerotic heart disease, n (%) | 124 (19.6) | 108 (20.1) | 16 (16.7) | 0.42 |
Dementia, n (%) | 47 (7.5) | 34 (6.4) | 13 (13.5) | 0.014 |
Height, cm, mean (SD) | 157.6 (9.5) | 158.2 (9.4) | 154.3 (9.1) | < 0.001 |
Weight, kg, mean (SD) | 71.4 (12.6) | 73.8 (11.8) | 58 (8.4) | < 0.001 |
BMI, kg/m2, mean (SD) | 28.7 (4.9) | 29.5 (4.8) | 24.4 (3.7) | < 0.001 |
Calf circumference, cm, mean (SD) | 36.1 (3.77) | 37.1 (3.17) | 30.7 (1.7) | < 0.001 |
Handgrip strength, kg, mean (SD) | 21.7 (7.6) | 22.3 (7.7) | 18 (6) | < 0.001 |
Gait Speed, m/s, mean (SD) | 1.01 (0.31) | 1.02 (0.31) | 0.91 (0.34) | 0.005 |
ADL, median(min-max) | 6 (0–6) | 6 (0–6) | 6 (1–6) | 0.019 |
IADL, median(min-max) | 8 (0–8) | 8 (0–8) | 8 (0–8) | 0.001 |
MNA-SF, median(min-max) | 13 (4–14) | 13 (5–14) | 11 (4–14) | < 0.001 |
GDS, median(min-max) | 2 (0–15) | 2 (0–15) | 2 (0–15) | 0.025 |
Sedimentation, mm/h median (min-max) | 18 (3–49) | 18 (3–49) | 19 (4–49) | 0.34 |
C- reactive protein, mg/L median (min-max) | 3.1 (0.2–9.9) | 3.1 (1-9.9) | 2.9 (0.2–9.3) | 0.18 |
Neutrophil (109/uL) median (min-max) | 3.9 (1.5–9.6) | 3.9 (1.5–9.6) | 4.2 (1.9-9) | 0.022 |
Lymphocytes (109/uL), median (min-max) | 1.8 (1.0-4.7) | 1.9 (1-4.7) | 1.7 (1-4.6) | 0.007 |
Platelet (109/uL), median (min-max) | 235 (116–434) | 234 (116–434) | 240 (137–405) | 0.19 |
SII, median (min-max) | 486.5 (154.8–1729) | 468 (154.8–1729) | 594.6 (225–1593) | < 0.001 |